HLA-C*05:01 and HLA-C*04:01 share similar peptide preferences at p3 for Asp and conserved hydrophobic residues at the C-terminus, but differ significantly at p2 with HLA-C*04:01 preferring large aromatic residues (Phe, Tyr and Trp) and HLA-C*05:01 preferring smaller residues such as Ala and Ser (Fig
Tesofensine has emerged as a compelling option in weight management research, showing promise in helping individuals achieve significant weight reduction while positively influencing metabolic health
To address scenarios where high purities are essential, we developed a purification protocol that takes advantage of the possibility of using HPDP-biotin with SpyLock (Fig
IGF-1 LR3 is not FDA-approved for human use
[DOI] [PubMed] [Google Scholar] 6.Shah DR, Daver N, Borthakur G, Hirsch-Ginsberg C, Oo TH
The GSSG/GSH Quantification kit contains the Masking Reagent of GSH